Back to top

Image: Bigstock

BioMarin (BMRN) in Focus: Stock Moves 7.5% Higher

Read MoreHide Full Article

BioMarin Pharmaceutical Inc. (BMRN - Free Report) was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $80.35 –$88.51 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen seven negative estimate revisions in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

BioMarin currently has a Zacks Rank #3 (Hold) while its  Earnings ESP  is negative.

BioMarin Pharmaceutical Inc. Price

Investors interested in the Medical - Biomedical and Genetics industry may consider Anika Therapeutics, Inc. (ANIK - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is BMRN going up? Or down? Predict to see what others think: Up or Down

Radical New Technology Creates $12.3 Trillion Opportunity

Imagine buying Microsoft stock in the early days of personal computers… or Motorola after it released the world’s first cell phone. These technologies changed our lives and created massive profits for investors.

Today, we’re on the brink of the next quantum leap in technology. 7 innovative companies are leading this “4th Industrial Revolution” - and early investors stand to earn the biggest profits.

See the 7 breakthrough stocks now>>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Anika Therapeutics Inc. (ANIK) - free report >>

BioMarin Pharmaceutical Inc. (BMRN) - free report >>

More from Zacks Tale of the Tape

You May Like

Published in